Date(s) - 10 Sep 2014
10:00 AM - 11:00 AM
The Biodesign Institute at ASU
Biodesign Discovery Series: Crossing Barriers in Alzheimer’s Drug Development
Wednesday, Sept. 10, 10 a.m.
Biodesign Institute, Auditorium B105, 727 E. Tyler St., Tempe, AZ 85287
Dr. Ryan Watts, Director and Senior Scientist, Department of Neuroscience, Genentech
Ryan Watts leads 10 Genentech laboratories focused on developing therapies for Alzheimer’s and Parkinson’s diseases, ALS, pain and other neurological disorders. His research on the blood-brain barrier focuses on the ability of large molecules to transverse it. This effort has led to a new Alzheimer’s therapy and a pipeline of large molecule drugs focused on diseases affecting the central nervous system.
Can’t attend? Watch the seminar live via webcast or on-demand. More information